Biopharmaceutical

Summary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the first investigational long-acting antibody, designed to protect…

Synopsis : Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, announced the appointment of Serina Fischer as its General Manager…

Summary : Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the…

Summary : Johnson & Johnson’s partner, Legend Biotech, has been awarded U.S. Food and Drug Administration approval for its chimeric antigen receptor…

Summary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…

Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…

Winners Announced in 16th Annual Stevie® Awards for Sales & Customer Service New Categories for 2022 Recognize Thought Leadership FAIRFAX, Va., March…

Summary : – In the FDA-conducted study, SAB-185 consistently demonstrated high avidity and high potency for effectively neutralizing a broad range of…

Summary : Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with…

Summary : A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the…